Back
Serum S100B Levels in Melanoma.
Journal article

Serum S100B Levels in Melanoma.

  • Frauchiger AL Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Dummer R Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
  • Mangana J Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. johanna.mangana@usz.ch.
  • 2019-02-03
Published in:
  • Methods in molecular biology (Clifton, N.J.). - 2019
Calcium
EF hand
Follow-up
Melanoma
S100B
Staging
Therapy monitoring
Biomarkers, Tumor
Early Detection of Cancer
Gene Expression Regulation, Neoplastic
Humans
Immunoassay
Melanoma
Neoplasm Grading
Neoplasm Staging
Prognosis
S100 Calcium Binding Protein beta Subunit
Survival Analysis
Tumor Suppressor Protein p53
English Malignant melanoma is a cancer with increasing incidence worldwide with relevant socioeconomic impact. Despite progress in prevention and early detection, it is one of the most lethal forms of skin cancer. Therefore it is urgent need to identify suitable biomarkers in order to improve early diagnosis, precise staging, and prognosis, as well as for therapy selection and monitoring. In this book chapter, we are focusing on S100B and discuss its clinical relevance in melanoma.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/128476
Statistics
Document views: 24 File downloads: